Value of carvedilol in congestive heart failure secondary to coronary artery disease
- 1 November 1990
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (15) , 1118-1123
- https://doi.org/10.1016/0002-9149(90)90515-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effects of a new vasodilating beta-blocking drug, carvedilol, on left ventricular function in stable angina pectorisThe American Journal of Cardiology, 1987
- Carvedilol for systemic hypertensionThe American Journal of Cardiology, 1987
- Antianginal efficacy of carvedilol, a beta-blocking drug with vasodilating activityThe American Journal of Cardiology, 1986
- Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.Circulation, 1985
- Rationale for beta-adrenergic blocking drugs in cardiomyopathyThe American Journal of Cardiology, 1985
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Long-term antianginal action of verapamil assessed with quantitated serial treadmill stress testingThe American Journal of Cardiology, 1981
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975
- Propranolol in the Treatment of Acute Myocardial InfarctionCirculation, 1974